roche - Search News

News

Roche, Eye Drug Vabysmo

The Wall Street Journal on MSN · 5h

Roche Sales Rise, Boosted By Key Drugs

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss francs ($18.

Reuters on MSN · 7h

Roche Q1 sales up 7% on drugs Phesgo, Vabysmo

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye drug Vabysmo and allergy treatment Xolair. Quarterly group revenues came in at 15.

MarketWatch · 2d

Roche Sales Expected to Rise, Eye Drug Vabysmo in Focus -- Earnings Preview

Roche has a significant manufacturing footprint in the U.S. and has just announced that it will invest $50 billion in research and manufacturing across the country. However, it

Swiss pharma giant Roche pledges to invest €47 billion in US

Associated Press News on MSN · 1d

Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and create 12,000 jobs.

Dealbreaker on MSN · 18h

Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital expenditure push as drugmakers prepare for expected tariffs from the Trump administration.

Benzinga on MSN · 1d

Roche Pledges $50 Billion U.S. Investment To Expand Manufacturing And R&D As Trump Threatens Pharma Tariffs

Roche announced a $50 billion investment in the U.S. over the next five years, according to CNBC. The move aims to expand its manufacturing and R&D footprint amid tariff threats from President Donald Trump.

4hon MSN

Roche seeks US tariff relief in direct talks with Trump administration

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche seeking talks with the US on tariff exemptions

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

Roche in ‘Very, Very Good Position’ to Weather Trump Tariffs, But M&A May Suffer

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

8h

Roche says Q1 sales up 7%, confirms guidance

Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...

1h

Roche introduces algorithm for ACS detection in individuals with chest pain

Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This ...

1d

Roche pours $50 billion into U.S. manufacturing; at least one new plant will be in Indiana

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

1don MSN

Roche to Invest $50 Billion in U.S. Manufacturing, R&D as Tariffs Loom

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

DPA International on MSN4h

Roche posts 7% increase in first quarter group sales

Roche Holding, the Swiss pharmaceutical giant, said on Thursday that its group sales rose by 7% in the first quarter to 14.4 ...

1d

Roche plans $50B expansion in US, including NJ, as drugmakers grapple with Trump tariffs

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results